Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Hodgkin's Disease; Non-Hodgkin Lymphomas; Multiple Myelomas
Intervention: Drug: lenograstim
Sponsors: WiSP Wissenschaftlicher Service Pharma GmbH; Ludwig-Maximilians - University of Munich; Chugai Pharma GmbH
Completed - verified March 2010